Login / Signup
Overall Survival Analysis of the Use of Elotuzumab in ELOQUENT-3 Trial.
Samer Al Hadidi
Frits Van Rhee
Published in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Keyphrases
</>
phase iii
study protocol
phase ii
clinical trial
randomized controlled trial
double blind